nach oben

Journal of Neurology

Erschienen in:

01.08.2023 | Original Communication

The cysteine-altering p.R544C variant in the NOTCH3 gene is a probable candidate for blood pressure and relevant traits in the Taiwan Biobank

verfasst von: Eugene Lin, Po-Hsiu Kuo, Yu-Li Liu, Tso-Jen Wang, Albert C. Yang, Shih-Jen Tsai

Erschienen in: Journal of Neurology | Ausgabe 11/2023

Einloggen, um Zugang zu erhalten

Abstract

Background

The cysteine-altering variants in NOTCH3 have been suggested to be associated with stroke, dementia, and cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy (CADASIL), where aberrant blood pressure levels represent the characteristics of these diseases. We aimed to assess whether the cysteine-altering p.Arg544Cys (p.R544C; rs201118034) variant and common single nucleotide variants (SNVs) in NOTCH3 could contribute to systolic and diastolic blood pressure and related phenotypes in the Taiwan Biobank.

Methods

We employed a discovery sample of 68,925 individuals, an independent replication sample of 45,676 individuals, and a combined/total sample of 114,601 individuals; all from the Taiwan Biobank. Blood pressure, such as systolic and diastolic blood pressure, was measured for all participants. Association was evaluated using a general linear model, where results were considered statistically significant if the P value < 0.05 divided by the number of independent tests per model.

Results

From our analysis, we identified and replicated three novel candidates for blood pressure that have not previously been reported: the cysteine-altering p.R544C variant for systolic blood pressure, the common SNV rs11669950 for diastolic blood pressure, and the common SNV rs4808235 for diastolic blood pressure. We also generalized two previously identified SNVs (i.e., rs10418305 and rs7408868) in NOTCH3 for blood pressure in European and non-Taiwanese East Asian populations to the Taiwanese population. Moreover, the participants with NOTCH3 p.R544C had an increased stroke frequency (P < 1.0 × 10^–5) and a higher dementia frequency (P = 2.0 × 10^–4) compared with the whole Taiwan Biobank population in the combined/total sample.

Conclusion

NOTCH3 is a strong candidate for a role in stroke, dementia, and CADASIL, which has previously been linked to blood pressure changes. While our preliminary study suggests that NOTCH3 p.R544C may influence blood pressure, stroke, and dementia in the Taiwan Biobank, replication in a well-powered external sample is required. This study also underlines considerable prospects of detecting novel genetic biomarkers in underrepresented worldwide populations.

Nur mit Berechtigung zugänglich

Belin de Chantemele E, Retailleau K, Pinaud F, Vessières E, Bocquet A, Guihot A-L, Lemaire B, Domenga V, Baufreton C, Loufrani L (2008) Notch3 is a major regulator of vascular tone in cerebral and tail resistance arteries. Arterioscler Thromb Vasc Biol 28:2216–2224PubMedCrossRef

Boulos N, Helle F, Dussaule J-C, Placier S, Milliez P, Djudjaj S, Guerrot D, Joutel A, Ronco P, Boffa J-J (2011) Notch3 is essential for regulation of the renal vascular tone. Hypertension 57:1176–1182PubMedCrossRef

Cheng YW, Chen CH, Hu CJ, Chiou HY, Tang SC, Jeng JS (2020) Imaging-based pregenetic screening for NOTCH3 p. R544C mutation in ischemic stroke in Taiwan. Ann Clin Transl Neurol 7:1951–1961PubMedPubMedCentralCrossRef

Cho BP, Nannoni S, Harshfield EL, Tozer D, Gräf S, Bell S, Markus HS (2021) NOTCH3 variants are more common than expected in the general population and associated with stroke and vascular dementia: an analysis of 200 000 participants. J Neurol Neurosurg Psychiatry 92:694–701PubMedCrossRef

Consortium G, Ardlie KG, Deluca DS, Segrè AV, Sullivan TJ, Young TR, Gelfand ET, Trowbridge CA, Maller JB, Tukiainen T (2015) The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348:648–660CrossRef

Das S, Forer L, Schönherr S, Sidore C, Locke AE, Kwong A, Vrieze SI, Chew EY, Levy S, McGue M (2016) Next-generation genotype imputation service and methods. Nat Genet 48:1284–1287PubMedPubMedCentralCrossRef

Freiberg JJ, Tybjærg-Hansen A, Jensen JS, Nordestgaard BG (2008) Nonfasting triglycerides and risk of ischemic stroke in the general population. JAMA 300:2142–2152PubMedCrossRef

Giri A, Hellwege JN, Keaton JM, Park J, Qiu C, Warren HR, Torstenson ES, Kovesdy CP, Sun YV, Wilson OD (2019) Trans-ethnic association study of blood pressure determinants in over 750,000 individuals. Nat Genet 51:51–62PubMedCrossRef

Guo L, Jiao B, Liao X, Xiao X, Zhang W, Yuan Z, Liu X, Zhou L, Wang X, Zhu Y (2021) The role of NOTCH3 variants in Alzheimer’s disease and subcortical vascular dementia in the Chinese population. CNS Neurosci Therapeutics 27(8):930–940CrossRef

10.

Hack RJ, Rutten JW, Person TN, Li J, Khan A, Griessenauer CJ, Center RG, Abedi V, Lesnik Oberstein SA, Zand R (2020) Cysteine-altering NOTCH3 variants are a risk factor for stroke in the elderly population. Stroke 51:3562–3569PubMedPubMedCentralCrossRef

11.

Hoffmann TJ, Ehret GB, Nandakumar P, Ranatunga D, Schaefer C, Kwok P-Y, Iribarren C, Chakravarti A, Risch N (2017) Genome-wide association analyses using electronic health records identify new loci influencing blood pressure variation. Nat Genet 49:54–64PubMedCrossRef

12.

Joutel A, Corpechot C, Ducros A, Vahedi K, Chabriat H, Mouton P, Alamowitch S, Domenga V, Cécillion M, Maréchal E (1996) Notch3 mutations in CADASIL, a hereditary adult-onset condition causing stroke and dementia. Nature 383:707–710PubMedCrossRef

13.

Lawes CM, Bennett DA, Feigin VL, Rodgers A (2004) Blood pressure and stroke: an overview of published reviews. Stroke 35:776–785PubMedCrossRef

14.

Lee Y-C, Chung C-P, Chang M-H, Wang S-J, Liao Y-C (2020) NOTCH3 cysteine-altering variant is an important risk factor for stroke in the Taiwanese population. Neurology 94:e87–e96PubMedCrossRef

15.

Lewington S, Lacey B, Clarke R, Guo Y, Kong XL, Yang L, Chen Y, Bian Z, Chen J, Meng J (2016) The burden of hypertension and associated risk for cardiovascular mortality in China. JAMA Intern Med 176:524–532PubMedCrossRef

16.

Li X, Zhang X, Leathers R, Makino A, Huang C, Parsa P, Macias J, Yuan JX, Jamieson SW, Thistlethwaite PA (2009) Notch3 signaling promotes the development of pulmonary arterial hypertension. Nat Med 15:1289–1297PubMedPubMedCentralCrossRef

17.

Liao Y-C, Hsiao C-T, Fuh J-L, Chern C-M, Lee W-J, Guo Y-C, Wang S-J, Lee I-H, Liu Y-T, Wang Y-F (2015) Characterization of CADASIL among the Han Chinese in Taiwan: distinct genotypic and phenotypic profiles. PLoS ONE 10:e0136501PubMedPubMedCentralCrossRef

18.

Lin E, Kuo P-H, Lin W-Y, Liu Y-L, Yang AC, Tsai S-J (2021) An association study in the Taiwan Biobank elicits three novel candidates for cognitive aging in old adults: NCAM1, TTC12 and ZBTB20. Aging (Albany NY) 13:18769PubMedCrossRef

19.

Lin E, Kuo P-H, Lin W-Y, Liu Y-L, Yang AC, Tsai S-J (2021) Prediction of probable major depressive disorder in the Taiwan Biobank: an integrated machine learning and genome-wide analysis approach. J Personalized Med 11:597CrossRef

20.

Lin E, Tsai S-J, Kuo P-H, Liu Y-L, Yang AC, Conomos MP, Thornton TA (2021) Genome-wide association study in the Taiwan biobank identifies four novel genes for human height: NABP2, RASA2, RNF41 and SLC39A5. Hum Mol Genet 30:2362–2369PubMedCrossRef

21.

Matz K, Keresztes K, Tatschl C, Nowotny M, Dachenhausen A, Brainin M, Tuomilehto J (2006) Disorders of glucose metabolism in acute stroke patients: an underrecognized problem. Diabetes Care 29:792–797PubMedCrossRef

22.

Monet M, Domenga V, Lemaire B, Souilhol C, Langa F, Babinet C, Gridley T, Tournier-Lasserve E, Cohen-Tannoudji M, Joutel A (2007) The archetypal R90C CADASIL–NOTCH3 mutation retains NOTCH3 function in vivo. Hum Mol Genet 16:982–992PubMedCrossRef

23.

Morris H, Neves K, Montezano A, Joutel A, Maclean M, Touyz R (2021) CADASIL-causing Notch3 mutation contributes to the development of pulmonary arterial hypertension in males. J Hypertens 39:e326CrossRef

24.

Muiño E, Gallego-Fabrega C, Cullell N, Carrera C, Torres N, Krupinski J, Roquer J, Montaner J, Fernández-Cadenas I (2017) Systematic review of cysteine-sparing NOTCH3 missense mutations in patients with clinical suspicion of CADASIL. Int J Mol Sci 18:1964PubMedPubMedCentralCrossRef

25.

Purcell S, Neale B, Todd-Brown K, Thomas L, Ferreira MA, Bender D, Maller J, Sklar P, de Bakker PI, Daly MJ, Sham PC (2007) PLINK: a tool set for whole-genome association and population-based linkage analyses. Am J Hum Genet 81:559–575PubMedPubMedCentralCrossRef

26.

Qiu C, Winblad B, Fratiglioni L (2005) The age-dependent relation of blood pressure to cognitive function and dementia. Lancet Neurol 4:487–499PubMedCrossRef

27.

Ragot H, Monfort A, Baudet M, Azibani F, Fazal L, Merval R, Polidano E, Cohen-Solal A, Delcayre C, Vodovar N (2016) Loss of Notch3 signaling in vascular smooth muscle cells promotes severe heart failure upon hypertension. Hypertension 68:392–400PubMedCrossRef

28.

Rufa A, Dotti MT, Franchi M, Stromillo ML, Cevenini G, Bianchi S, De Stefano N, Federico A (2005) Systemic blood pressure profile in cerebral autosomal dominant arteriopathy with subcortical infarcts and leukoencephalopathy. Stroke 36:2554–2558PubMedCrossRef

29.

Rutten JW, Haan J, Terwindt GM, Van Duinen SG, Boon EM, Lesnik Oberstein SA (2014) Interpretation of NOTCH3 mutations in the diagnosis of CADASIL. Expert Rev Mol Diagn 14:593–603PubMedCrossRef

30.

Rutten JW, Hack RJ, Duering M, Gravesteijn G, Dauwerse JG, Overzier M, van den Akker EB, Slagboom E, Holstege H, Nho K (2020) Broad phenotype of cysteine-altering NOTCH3 variants in UK Biobank: CADASIL to nonpenetrance. Neurology 95:e1835–e1843PubMedPubMedCentralCrossRef

31.

Schmidt H, Zeginigg M, Wiltgen M, Freudenberger P, Petrovic K, Cavalieri M, Gider P, Enzinger C, Fornage M, Debette S (2011) Genetic variants of the NOTCH3 gene in the elderly and magnetic resonance imaging correlates of age-related cerebral small vessel disease. Brain 134:3384–3397PubMedPubMedCentralCrossRef

32.

Selvin S (2004) Statistical analysis of epidemiologic data. Oxford University PressCrossRef

33.

Tang SC, Chen YR, Chi NF, Chen CH, Cheng YW, Hsieh FI, Hsieh YC, Yeh HL, Sung PS, Hu CJ (2019) Prevalence and clinical characteristics of stroke patients with p. R544C NOTCH3 mutation in Taiwan. Ann Clin Transl Neurol 6:121–128PubMedCrossRef

34.

Tirschwell D, Smith N, Heckbert S, Lemaitre R, Longstreth W, Psaty B (2004) Association of cholesterol with stroke risk varies in stroke subtypes and patient subgroups. Neurology 63:1868–1875PubMedCrossRef

35.

Viswanathan A, Guichard J-P, Gschwendtner A, Buffon F, Cumurcuic R, Boutron C, Vicaut E, Holtmannspötter M, Pachai C, Bousser M-G (2006) Blood pressure and haemoglobin A1c are associated with microhaemorrhage in CADASIL: a two-centre cohort study. Brain 129:2375–2383PubMedCrossRef

36.

Wang Y-F, Liao Y-C, Tzeng Y-S, Chen S-P, Lirng J-F, Fuh J-L, Chen W-T, Lai K-L, Lee Y-C, Wang S-J (2022) Mutation screening and association analysis of NOTCH3 p. R544C in patients with migraine with or without aura. Cephalalgia 42:888–898PubMedCrossRef

37.

Ward LD, Kellis M (2016) HaploReg v4: systematic mining of putative causal variants, cell types, regulators and target genes for human complex traits and disease. Nucleic Acids Res 44:D877–D881PubMedCrossRef

38.

Warren HR, Evangelou E, Cabrera CP, Gao H, Ren M, Mifsud B, Ntalla I, Surendran P, Liu C, Cook JP (2017) Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat Genet 49:403–415PubMedPubMedCentralCrossRef

39.

Wei C-Y, Yang J-H, Yeh E-C, Tsai M-F, Kao H-J, Lo C-Z, Chang L-P, Lin W-J, Hsieh F-J, Belsare S (2021) Genetic profiles of 103,106 individuals in the Taiwan Biobank provide insights into the health and history of Han Chinese. NPJ Genom Med 6:1–10CrossRef

40.

Westra H-J, Peters MJ, Esko T, Yaghootkar H, Schurmann C, Kettunen J, Christiansen MW, Fairfax BP, Schramm K, Powell JE (2013) Systematic identification of trans eQTLs as putative drivers of known disease associations. Nat Genet 45:1238–1243PubMedPubMedCentralCrossRef

41.

Willmot M, Leonardi-Bee J, Bath PM (2004) High blood pressure in acute stroke and subsequent outcome: a systematic review. Hypertension 43:18–24PubMedCrossRef

42.

Yoon CW, Kim Y-E, Kim HJ, Ki C-S, Lee H, Rha J-H, Na DL, Seo SW (2021) Comparison of longitudinal changes of cerebral small vessel disease markers and cognitive function between subcortical vascular mild cognitive impairment with and without NOTCH3 variant: a 5-year follow-up study. Front Neurol 12:242CrossRef

43.

Zhan X, Hu Y, Li B, Abecasis GR, Liu DJ (2016) RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinformatics 32:1423–1426PubMedPubMedCentralCrossRef

Titel: The cysteine-altering p.R544C variant in the NOTCH3 gene is a probable candidate for blood pressure and relevant traits in the Taiwan Biobank
verfasst von: Eugene Lin
Po-Hsiu Kuo
Yu-Li Liu
Tso-Jen Wang
Albert C. Yang
Shih-Jen Tsai
Publikationsdatum: 01.08.2023
Verlag: Springer Berlin Heidelberg
Erschienen in: Journal of Neurology / Ausgabe 11/2023
Print ISSN: 0340-5354
Elektronische ISSN: 1432-1459
DOI: https://doi.org/10.1007/s00415-023-11909-6

Leitlinien kompakt für die Neurologie

Mit medbee Pocketcards sicher entscheiden.

^{Seit 2022 gehört die medbee GmbH zum Springer Medizin Verlag}

Kostenlos registrieren

Neu im Fachgebiet Neurologie

Nicht Creutzfeldt Jakob, sondern Abführtee-Vergiftung

29.05.2024 Hyponatriämie Nachrichten

Eine ältere Frau trinkt regelmäßig Sennesblättertee gegen ihre Verstopfung. Der scheint plötzlich gut zu wirken. Auf Durchfall und Erbrechen folgt allerdings eine Hyponatriämie. Nach deren Korrektur kommt es plötzlich zu progredienten Kognitions- und Verhaltensstörungen.

Schutz der Synapsen bei Alzheimer

29.05.2024 Morbus Alzheimer Nachrichten

Mit einem Neurotrophin-Rezeptor-Modulator lässt sich möglicherweise eine bestehende Alzheimerdemenz etwas abschwächen: Erste Phase-2-Daten deuten auf einen verbesserten Synapsenschutz.

Sozialer Aufstieg verringert Demenzgefahr

24.05.2024 Demenz Nachrichten

Ein hohes soziales Niveau ist mit die beste Versicherung gegen eine Demenz. Noch geringer ist das Demenzrisiko für Menschen, die sozial aufsteigen: Sie gewinnen fast zwei demenzfreie Lebensjahre. Umgekehrt steigt die Demenzgefahr beim sozialen Abstieg.

Hirnblutung unter DOAK und VKA ähnlich bedrohlich

17.05.2024 Direkte orale Antikoagulanzien Nachrichten

Kommt es zu einer nichttraumatischen Hirnblutung, spielt es keine große Rolle, ob die Betroffenen zuvor direkt wirksame orale Antikoagulanzien oder Marcumar bekommen haben: Die Prognose ist ähnlich schlecht.

Update Neurologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Abstract

Background

Methods

Results

Conclusion

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 11/2023

Multiple sclerosis lesions that impair memory map to a connected memory circuit

Retreating migraine patients in the second year with monoclonal antibodies anti-CGRP pathway: the multicenter prospective cohort RE-DO study

Comprehensive pathological and genetic investigation of three young adult myotonic dystrophy type 1 patients with sudden unexpected death

Anxiety and physical impairment in patients with central vestibular disorders

Characteristics of primary Sjögren’s syndrome-associated peripheral nervous system lesions